Humacyte, Inc. Common Stock
Symbol: HUMA (NASDAQ)
1.46
▼ (-2.67%) -0.040
Company Description:
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Key Stats
- Today's Open: $1.51
- Today's High: $1.525
- Today's Low: $1.455
- Today's Volume: 2.05M
- Yesterday Close: $1.5
- Yesterday High: $1.5
- Yesterday Low: $1.38
- Yesterday Volume: 3.26M
- Last Min Volume: 140
- Last Min High: $1.46
- Last Min Low: $1.46
- Last Min VWAP: $1.46
Company Profile
- Name: Humacyte, Inc. Common Stock
- Website: https://www.humacyte.com
- Listed Date: 2021-08-27
- Location: DURHAM, NC
- Market Status: Active
- CIK Number: 0001818382
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $223.30M
- Round Lot: 100
- Outstanding Shares: 158.37M
- Asset Type: CS
RECENT FILINGS FOR HUMA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-20 | 4 | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 144 | View |
| 2025-08-19 | 144 | View |
| 2025-08-18 | 144 | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-11 | 8-K | View |
Latest News on HUMA